Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records

INTRODUCTION: Preliminary data suggest that dipeptidyl peptidase-4 (DPP-4) inhibitors may reduce microvascular events, but there is a little evidence to support this from adequate real-world studies. This study aimed to compare microvascular outcomes between patients-prescribed vildagliptin and thos...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Diabetes Ther
Главные авторы: Kolaczynski, Wlodzimierz M., Hankins, Matthew, Ong, Siew H., Richter, Hartmut, Clemens, Andreas, Toussi, Massoud
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Healthcare 2016
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5014784/
https://ncbi.nlm.nih.gov/pubmed/27262995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-016-0177-8
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы